baber/WOPTO huggingface dataset:
Patent JP-3118382-B2 (JP)
IPC: F04D27/00
Filed: 1994-11-11
Granted: 2000-12-18
Abstract: PURPOSE: To prevent beat of a vibration sound by a method wherein a plurality of room fan motors are arranged to feed air into a room through a room heat exchanger and are each controlled so that the respective rotational speeds of the plurality of room fan motors causes a difference exceeding a specified value therebetween. CONSTITUTION: An air conditioner is provided with a room heat exchanger to perform a room heat exchange using a refrigerant and adjust at least one of the temperature and the humidity in a room by heat exchange with the room heat exchanger. The air conditioner is provided with a plurality of room fan motors 70MA and 70MA to feed air into the room through the room heat exchanger. Here, the plurality of room fan motors 70MA and 70MB are controlled by the room fan motor 70MA/70MB control means so that the respective rotational speeds of the plurality of room fan motors 70MA and 70MB cause a difference exceeding a specified value therebetween 70MA and 70MB. In other words, the control is made to obtain the difference that allows the elimination of the beat of mechanical vibration sound obnoxious to hear attributed to varied rotational speeds among the plurality of room fan motors 70MA and 70MB.
Patent JP-3183729-B2 (JP)
IPC: C07C237/26
Filed: 1992-09-28
Granted: 2001-07-09
Abstract: Novel 9-amino-7-(substituted amino)-6-demethyl-6-deoxytetracyclines having activity against a wide spectrum of organisms including organisms which are resistant to tetracyclines are disclosed. Also disclosed are intermediates and methods for making the novel compounds of the present invention.
Patent JP-2789045-B2 (JP)
IPC: C07C51/367
Filed: 1989-11-01
Granted: 1998-08-20
Abstract: This process is characterized by the fact that glyoxylic acid in aqueous solution is reacted with an excess of phenol in the presence of a tertiary amine, insoluble or slightly soluble in water and liquid at ambient temperature, in particular tributylamine or triisooctylamine, then the parahydroxymandelic acid thus obtained is salified with sodium hydroxide in aqueous solution. The reaction of the glyoxylic acid with phenol is carried out at a temperature between 15 DEG  C. and 80 DEG  C.
Patent JP-H0653661-B2 (JP)
IPC: A61K31/785
Filed: 1987-12-02
Abstract: The present invention provides a process of making N<1>,N4diethylspermine having the general formula:   CH<7>CH<6>-N<1>H-(CH<6>)<7>-N<2>H-(CH<6>)<8>-N<3>H-(CH<6>)<7>-N4H-CH<6 >CH<7>.    and pharmaceutically acceptable salts thereof by reacting spermine:    N<1>H<6>-(CH<6>)<7>-N<2>H-(CH<6>)<8>-N<3>H-(CH<6>)<7>-N4H<6>   with a sulfonating agent of the general formula RSO<6>X, where X stands for a leaving group and RSO<6> stands for a sulfonyl protecting group, e.g. an alkyl-, aralkyl- or aryl- sulfonyl protecting group, in the presence of a base, reacting the compound thus produced: <CHEM> with a strong base, e.g. NaH, and an ethylating agent in an aprotic dipolar solvent to produce a compound of the general formula: <CHEM> and removing the protecting groups under reducing conditions to provide N<1>,N4 diethylspermine, which optionally is converted into a pharmaceutically acceptable acid addition salt.
Patent JP-H0653714-B2 (JP)
IPC: A61K31/17
Filed: 1989-12-15
Abstract: In accordance with the present invention, disclosed herein are compounds of the formula <CHEM> wherein R is straight or branched loweralkyl, R1 is hydrogen, straight or branched loweralkyl, lowercycloalkyl, amino, loweralkoxy or acylamino, and R2 is straight or branched loweralkyl, amino, cyclohexyl, morpholino, piperidino, tetrahydrofuranyl, dihydrofuranyl, tetrahydropyranyl, dioxolanyl, 2,2-dimethyl dioxolanyl, dioxanyl, pyrrolidinyl, tetrahydrooxazolyl, and dihydrooxazolyl, and pharmaceutically acceptable salts thereof. The compounds are useful in the treatment of glaucoma.
Patent JP-2807564-B2 (JP)
IPC: H04L12/56
Filed: 1990-11-27
Granted: 1998-10-08
Abstract: It consists, at the level of each terminal (2 to 9), in: 
 
  - continuing to transmit data cells after having transmitted a first cell, whilst waiting to receive a reception acknowledgement corresponding to this first cell; whilst limiting the number of cells transmitted during this wait, to a predetermined number W: 
  - then suspending transmission of cells during a predetermined period Trep, if the reception acknowledgement has not been received before having finished transmitting W cells; 
  - transmitting the first cell again if the corresponding reception acknowledgement has not been received during the period Trep; 
  - then freeing the connection occupied by the relevant terminal if the reception acknowledgement has not been received after a predetermined lag Tmax, measured from the first transmission of the first cell. 
 
<??>The predetermined values of W, Trep, and Tmax, are functions of the type of service afforded by the relevant terminals. 
<??>In the network (1), the control procedure consists, in the event of congestion, in: 
 
  - determining, for each connection, the values of the parameters W, Trep, Tmax, as a function of the type of service afforded by this connection; 
  - delaying sequences of W cells transmitted consecutively on each connection, whilst limiting the delay to a value less than Tmax; 
  - losing a cell and other identical cells transmitted on a connection, whilst limiting the period corresponding to this loss of cells to a value less than Tmax.
Patent JP-H0375569-B2 (JP)
IPC: C08J9/10
Filed: 1987-12-28
Abstract: Foamed elastomeric compositions are produced by a process comprising the steps of (A) forming a blend comprised of (1) a foamable, curable elastomer; (2) a curative; and (3) a blowing agent composition consisting essentially of (i) azodicarbonamide and (ii) at least one member selected from the group consisting of zinc salt of C1-C6 organic acids and C1-C6 carboxamides; and (B) heating such blend to between about 130 DEG C and about 170 DEG C for a period of time sufficient to foam and cure such blend.
Patent JP-H0710373-B2 (JP)
IPC: D04H1/68
Filed: 1990-12-05
Abstract: PCT No. PCT/GB90/01895 Sec. 371 Date Jun. 4, 1992 Sec. 102(e) Date Jun. 4, 1992 PCT Filed Dec. 5, 1990 PCT Pub. No. WO91/08037 PCT Pub. Date Jun. 13, 1991.A method of producing a particulate-solid-bearing air-permeable sheet of material of other than woven and knitted material selected from non-woven fabrics and open cell foam materials includes the following steps: entraining a particulate solid in a gaseous carrier in the substantial absence of fibrous material; disposing one face of a preformed air-permeable sheet material, which material has a density at or below 0.25 g/cm3, in the path of a stream of the gaseous carrier and entrained particulate solid, whilst maintaining a pressure drop across the thickness of the preformed air-permeable sheet material from the one face to the other face of the air-permeable sheet material, whereby to entrap some or all of the entrained particulate solid on or on and in the air-permeable material; and fixing the retained particulate solid on or on and in the air-permeable material with a binder. The mean pore size of the preformed sheet material is greater than the mean particle size of the particulate solid.
Patent JP-3426237-B2 (JP)
IPC: A61K35/18
Filed: 1994-05-27
Granted: 2003-07-14
Abstract: The present invention concerns the product produced by inactivating exracellular or intracellular pathogenic virus in a biological composition without incurring substantial disruption or inactivation of cells and without significant loss of labile proteins or other valuable biological components also contained therein, the inactivation process comprising subjecting said composition to a virucidally effective amount of irradiation in the presence of (a) a mixture of a compound that quenches type (I) photodynamic reactions and a compound that quenches type (II) photodynatic reactions of (b) a bifunctional compound that is capable of quenching both type (I) and type (II) reactions, to thereby inactivate said virus while retaining functionality of said composition. The composition is advantageously subjected to the irradiation and the mixture of compounds or bifunctional compound in the presence of an irradiation sensitizer. Moreover, the process can be advantageously combined with a different virucidal method to enhance virus inactivation.
Patent JP-H0681169-B2 (JP)
IPC: H04L27/34
Filed: 1988-12-16
Abstract: A quadrature amplitude modulation system utilizes two subcarrier signals, each quadrature modulated with information signals which are quadrature modulated onto the RF carrier. This provides a hole in the center of frequency spectrum, permitting carrier and bit sync signals can be provided in the center area of the signal spectrum.
Patent JP-2974028-B2 (JP)
IPC: C12P21/00
Filed: 1985-05-02
Granted: 1999-11-08
Abstract: An antigen which, as its major immunizing component, comprises a determinant of an adhesin polypeptide or an immunogenically active subsequence thereof or a precursor therefor which is convertible to an immunogenically active form, antibodies against which determinant react with the adhesin polypeptide produced by pathogenic adhesin-forming bacteria which adhere to mammalian tissue, antibodies against such antigen, and DNA expressing, as a principal gene product thereof, such antigen.
Patent JP-2584443-B2 (JP)
IPC: C12N15/09
Filed: 1986-04-17
Granted: 1997-02-26
Abstract: PCT No. PCT/US86/00817 Sec. 371 Date May 5, 1986 Sec. 102(e) Date May 5, 1986 PCT Filed Apr. 17, 1986 PCT Pub. No. WO86/06408 PCT Pub. Date Nov. 6, 1986.High yields of active Factor IX are produced by culturing a CHO cell line transfected with chromosomally-integrated Factor IX cDNA in medium to which vitamin K is added.
Patent JP-H0533048-B2 (JP)
IPC: A61B17/115
Filed: 1985-06-24
Abstract: 57 Surgical clip applying apparatus in which clips are delivered to a pair of jaws one at a time for closure around body tissue. The squeezing together of a pair of ring handles causes the jaws to move distally relative to the apparatus. The jaws contact a pair of inclined surfaces on the shaft of the apparatus and are thereby forced together, causing the distal-most clip in a linear array to be closed around body tissue. Release of the handles returns the jaws to the original positions so that another clip closing cycle can be initiated. An escapement mechanism interacts with the jaws to ensure that only one clip at a time from the linear array is delivered to the jaws. A clutch assembly ensures that each step in the clip closing and return cycle is completed in the proper sequence.
Patent JP-3274134-B2 (JP)
IPC: C04B14/10
Filed: 1992-08-06
Granted: 2002-04-15
Abstract: A laminated waterstop strip used in the construction of buildings that is placed on the top of a surface of a hardened concrete layer of footing, prior to pouring of an additional layer, and is made to have a number of granular layers held with adhesive between each of the layers, and having in the range of 30 to 60 individual granular layers so that the waterstop has a height of in the range of one-half to one inch. The waterstop strip is made up of bentonite granules, preferably, which are adhered to a fabric layer for support, an adhered layer on the exterior of the fabric layer, with a quick release paper on the exterior of the fabric layer. A light weight, synthetic fiber mesh for providing weather resistance, tear resistance, and retention properties is placed over the upper layer of particles. The waterstop strip is made in a batch process before being cut into strips by utilizing a reciprocating multi-station adhesive and particle dispensing carriage that will move back and forth across a desired size sheet of fabric until the number of layers of particles and adhesives have been built to the desired level and the adhesive forms an elastomeric matrix to retain the particles together.
Patent JP-3335351-B2 (JP)
IPC: G01N33/576
Filed: 1992-08-21
Granted: 2002-10-15
Abstract: Monoclonal antibodies which specifically bind to Hepatitis C Virus (HCV) E2/NS1 antigen. Also provided are hybridoma cell lines which secrete these monoclonal antibodies, methods for using these monoclonal antibodies, and assay kits for assays which contain these monoclonal antibodies.
Patent JP-3834336-B2 (JP)
IPC: B23B51/10
Filed: 1997-06-26
Granted: 2006-10-18
Abstract: A deburring tool for deburring the edges of boreholes. The tool has a base body in which at least one recess aligned across the longitudinal axis of the base body is provided, where at least one blade is arranged in said recess so it can be displaced under spring load in the longitudinal direction of the recess. A compression spring is provided in the longitudinal bore of the base body and comes in contact with one end of a control pin whose other end engages in a control recess in the blade to provide at least a holding power to the blade in the direction of displacement.
Patent JP-3955090-B2 (JP)
IPC: A61K8/34
Filed: 1994-07-19
Granted: 2007-08-08
Abstract: A preparation for stimulating the blood circulation of the skin comprising a dispersion containing a proportion of finely divided magnetically hard single-domain particles in the dispersion being in the range from 0.01% to 70% by weight, based on the total weight of the dispersion; these particles having a strong coercive field and being in the range 600 to 1200 nm; and the magnetically hard single-domain particles are selected from the group consisting of barium hexaferrite, strontium hexaferrite, undoped barium hexaferrite, undoped strontium hexaferrite, and the mixtures thereof; and the balance up to 100% by weight of a cosmetic or pharmaceutical excipient carrier substance or a pharmaceutical additive, based on the total weight of the dispersion.
Patent JP-3042714-B2 (JP)
IPC: G03C1/22
Filed: 1992-02-18
Granted: 2000-05-22
Abstract: PCT No. PCT/EP92/00335 Sec. 371 Date Oct. 13, 1992 Sec. 102(e) Date Oct. 13, 1992 PCT Filed Feb. 18, 1992 PCT Pub. No. WO92/15042 PCT Pub. Date Sep. 3, 1992.A photosensitive photographic silver halide material comprising a support bearing a layer of a silver halide emulsion comprising at least 50% silver chloride which contains in or adjacent the emulsion layer a hydrazide nucleating agent and an amine booster, the combination of which is capable of providing high contrast images, which emulsion is sensitised with a dye of the general formula: ally hydrogen, or halogen atom or an alkyl group of 1-4 carbon atoms, a sulfoalkyl, a trifluoromethyl, or cyano group, R3 is an alkyl or substituted alkyl group, R4 is a sulfoalkyl group, and R5 and R6 are individually an alkyl or substituted alkyl group, and wherein there is the necessary counter-ion.
Patent JP-3961567-B2 (JP)
IPC: C12N5/10
Filed: 1996-07-26
Granted: 2007-08-22
Abstract: Methods of production of desired recombinant proteins, polypeptides and peptides are disclosed which utilize mammalian host cells engineered for autonomous and regulated growth in low cost protein/serum-free culture media. Preferred host cells express insulin or an insulin-like growth factor, and/or transferrin and are engineered so that addition of an inducer (e.g., ZnCl2+CdCl2) halts growth and simultaneously induces the expression of the desired recombinant protein, polypeptide or peptide.
Patent JP-2828778-B2 (JP)
IPC: C07K14/54
Filed: 1993-09-01
Granted: 1998-11-25
Abstract: A method of restoring damaged or depleted cell populations by treating the patient with cytokines, particularly IL-11 and IL-6.
Patent JP-2991491-B2 (JP)
IPC: C08F26/10
Filed: 1990-06-14
Granted: 1999-12-20
Abstract: What is described herein is a precipitation polymerization process and terpolymer products produced thereby. Polymerization is carried out in a reaction mixture of a vinyl lactam, e.g. vinyl pyrrolidone or vinyl caprolactam, a polymerizable carboxylic acid, e.g. acrylic acid or methacrylic acid, and a hydrophobic monomer, e.g. lauryl methacrylate, in a predetermined compositional range, in the presence of a polymerization initiator, and in an aliphatic hydrocarbon solvent, particularly a C3-C10 saturated hydrocarbon, which is branched or unbranched, cyclic or acylic, and, preferably, is heptane or cyclohexane. The terpolymers are obtained in high yield, as a white powder, which can be filtered and dried easily.
Patent JP-4153561-B2 (JP)
IPC: A61B17/02
Filed: 1997-09-03
Granted: 2008-09-24
Abstract: A retractor support apparatus of the present invention includes a first support arm, a second support arm, and a first clamping member. The first and second support arms each have a pivot ball attached thereto. The first clamping member has a clamping bore that is adapted to receive and engage the pivot balls. The first clamping member retains the first and second support arms in a selected position when the clamp is in an open position. The first clamping member secures the first and second support arms in the selected position when the clamp is in clamping position.
Patent JP-3805371-B2 (JP)
IPC: C12N15/49
Filed: 1996-10-08
Granted: 2006-08-02
Abstract: The invention describes the expression of a human immunodeficiency virus (HIV) type 1 provirus (F12-HIV) cloned from a nonproducer, chronically-infected CD4 down-regulated Hut-78 cell clone (F12) which does not lead to the formation of viral particles and, upon transfection in HeLa CD4+ cells, confers resistance to HIV superinfection without affecting CD4 receptor exposure. A Moloney murine leukemia virus-based retroviral vector containing an F12-HIV genome lacking the 3' long terminal repeat (LTR) and part of the nef gene, expressed under the control of its 5' LTR, was constructed to facilitate the transfer of the anti-HIV properties of F12-HIV into human cells. The F12-HIV genome was inserted in an orientation opposite to that of the murine leukemia virus transcriptional unit and was designated the N2/F12-HIV nef- antisense vector. Lymphoblastoid CEMss cells, as well as human peripheral blood lymphocytes, were successfully transduced by the recombinant retrovirus. CEMss clones expressing the F12-HIV nef- antisense vector were resistant to HIV superinfection even at the highest multiplicity of infection tested (105 50% tissue culture infective doses per 106 cells). Nonproducer, interfering HIV proviruses transduced into retroviral vectors may provide an alternative strategy for the protection of CD4+ human primary cells from HIV infection.
Patent JP-2938569-B2 (JP)
IPC: A01K67/027
Filed: 1991-08-28
Granted: 1999-08-23
Abstract: A transgenic mouse having a genome comprising a human immunoglobulin heavy chain minilocus transgene, the transgene being capable of rearrangement and switching in the mouse, whereby two or more rearranged human heavy chain isotypes are produced.
Patent JP-3499246-B2 (JP)
IPC: C07D491/22
Filed: 1996-11-01
Granted: 2004-02-23
Abstract: PCT No. PCT/US96/17574 Sec. 371 Date May 14, 1998 Sec. 102(e) Date May 14, 1998 PCT Filed Nov. 1, 1996 PCT Pub. No. WO97/16454 PCT Pub. Date May 9, 1997The present invention relates to a process for preparing camptothecin and camptothecin analogs of Formula (I) from compounds of Formula (II) and to novel intermediates useful in their preparation, wherein R1 to R6 represent various substituents.
Patent JP-3414395-B2 (JP)
IPC: A61K35/76
Filed: 1991-10-17
Granted: 2003-06-09
Abstract: The production of artificial viral envelopes by a novel double-detergent dialysis technique is disclosed. Specifically exemplified is the production of HIV-1 and RSV viral envelopes. The resulting artificial viral envelopes are essentially identical to the natural virus with regard to characteristics which are relevant to immunogenicity.
Patent JP-3841440-B2 (JP)
IPC: B60T17/00
Filed: 1997-10-10
Granted: 2006-11-01
Abstract: A method and system for controlling the switching in of ancillary equipment driven by an engine of a vehicle, the ancillary equipment being arranged to be driven by the engine until at least a minimum operating level relating to the status of the ancillary equipment is attained. The method includes the steps of: determining in which of three modes the vehicle is in, these modes being a first mode in which the engine is driving the vehicle, a second mode in which the vehicle is being braked and a third mode in which the vehicle is coasting; and in the first mode causing the ancillary equipment to be switched in only if the status of the ancillary equipment is below a predetermined minimum level; in the second mode causing the ancillary equipment to be switched in if the status of the ancillary equipment is below a predetermined maximum level; and in the third mode causing the ancillary equipment to be switched in only if the status of the ancillary equipment is below a predetermined intermediate level between the maximum level and the minimum level.
Patent JP-3148249-B2 (JP)
IPC: C23C16/40
Filed: 1996-12-03
Granted: 2001-03-19
Abstract: PCT No. PCT/KR96/00230 Sec. 371 Date May 29, 1998 Sec. 102(e) Date May 29, 1998 PCT Filed Dec. 3, 1996 PCT Pub. No. WO97/20963 PCT Pub. Date Jun. 12, 1997An aluminum oxide film is economically and conveniently deposited on a substrate by a process which comprises vaporizing a dialkylaluminum alkoxide compound at a temperature ranging from 0 to 25 DEG  C. and contacting the resulting vapor with said substrate heated to a temperature ranging from 300 to 600 DEG  C.
Patent JP-3381194-B2 (JP)
IPC: B60C23/02
Filed: 1996-03-08
Granted: 2003-02-24
Abstract: A transponder and sensor apparatus with on-board power supply is mounted in or on a vehicle tire. A pressure sensor, a temperature sensor and a tire rotation sensor are mounted in a housing along with the transponder, the power supply and an antenna. Upon receiving an interrogation signal from a remote interrogator, the transponder activates the sensors to sense tire pressure and temperature and then backscatter-modulates the radio frequency signal from the interrogator with the tire condition parameter data from the sensors to return the backscatter modulated signal to the interrogator.
Patent JP-4467643-B2 (JP)
IPC: A61F6/06
Filed: 1997-02-14
Granted: 2010-05-26
Abstract: A condom has a ring (6) adjacent the open end (1) for expanding the condom to a maximum diameter to maintain the open end outside the vagina, and a tubular portion (3) extending between the ring and the closed end is of a size to form a loose fit around the penis and is formed with a series of circumferential grooves (5), e.g. 3 to 5 grooves around 0.8 cm wide and 1.0 cm deep, so that the condom naturally folds in a bellows like manner for the condom to collapse to a substantially flat condition prior to use.
Patent JP-4225432-B2 (JP)
IPC: F16B12/20
Filed: 1998-05-01
Granted: 2009-02-18
Abstract: A cam and expandable dowel type device is provided for joining together two members, e.g., furniture components. The cam is rotatably mounted in a first of the members and designed to engage a head portion of the sleeved dowel protruding from the second member. Rotation of the cam displaces the dowel relative to the sleeve, causing the end of the sleeve to expand and thus anchor the sleeved dowel in the second member. Further rotation of the cam causes the two members to be drawn tightly together. The camming element is designed to have a working rotational capacity of at least 190°.